SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Waiting for the big Kahuna -- Ignore unavailable to you. Want to Upgrade?


To: Haim R. Branisteanu who wrote (35465)12/19/1998 3:52:00 PM
From: William H Huebl  Read Replies (1) | Respond to of 94695
 
Haim,

In the Yahoo contest, my portfolio is up over 3% after a week...

The market itself is a mixed bag: sentiment indicators are mixed, VIX and VGY have bullish as well as bearish signals on them, options indicators are benign although put-call is low, mutual fund flows are very bearish, odd-lot short sales very bullish, and Market Watch is mixed in Barron's. However, the LNHNL indicator shows some concern that the market is getting mixed up internally and the SCY ratio is back down to 1.02 although it may continue to fall which is bullish until we get to the low .90s.

Watch out for the volatility!

Bill



To: Haim R. Branisteanu who wrote (35465)12/21/1998 8:28:00 AM
From: Henry Niman  Respond to of 94695
 
This morning Paine Webber and BBRS raised AMGN target price to $120 and $116 respectively and PW raise rating from ATTRACTIVE to BUY. Joe Kernan just gave an analysis of the NESP decision (said that Epogen was #1 seller for AMGN and JNJ and was most successful Biotech drug). Gordon Binder (AMGN CEO) will be on shortly. Details linked to Biotech Boom table at biocognizance.com